戻る Agenda
[V5-S4] Introduction to the Role of Medical Affairs for Research and Development Department
Session Chair(s)
Taku Seriu, MD, PHD
Executive Operating Officer, Head of New Product Evaluation & Development
Otsuka Pharmaceutical Co., Ltd., Japan
Takeharu Yamanaka, PHD
Professor, Department of Biostatics, School of Medicine
Yokohama City University, Japan
Speaker(s)
Introduction to the Role of Medical Affairs for Research and Development Department Role of Medical Affairs after Launching Products
Kazuya Iwamoto, MD, PHD, FACP
Senior Medical Director, Covance Inc., Japan
Chairperson, The Japanese Association of Pharmaceutical Medicine (JAPhMed)
Role of Medical Affairs in Development Phase
Masahiro Tamura
Sanofi K.K., Japan
Head, Post Marketing Clinical Research, Medical Operations
Medical Affairs Department in Japan: Current Status and Issues
Eiji Harada, MD, MBA
Novartis Pharma K.K., Japan
Medical Affairs Department in Japan: Current Status and Issues
Koji Iwasaki, PHD
Osaka University Hospital, Japan
Professor, Academic Clinical Research Center,